Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson, Nicholas G. Minutolo, Saar Gill, et al.
Cancer Research (2020) Vol. 81, Iss. 5, pp. 1201-1208
Open Access | Times Cited: 485

Showing 1-25 of 485 citing articles:

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 271
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Jing Gao, Yuanzheng Liang, Liang Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 237
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 234
The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
Huogang Wang, Mingo M. H. Yung, Hys Ngan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6560-6560
Open Access | Times Cited: 176
Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment
Shuang Wang, Feng Li, Tong Ye, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 615
Closed Access | Times Cited: 148
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 136
Targeting tumor-associated macrophages for cancer treatment
Mengjun Li, Linye He, Jing Zhu, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 125
Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
Weiwei Zeng, Mian Yu, Ting Chen, et al.
Advanced Science (2022) Vol. 9, Iss. 23
Open Access | Times Cited: 111
Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy
Qingqing Feng, Xiaotu Ma, Keman Cheng, et al.
Advanced Materials (2022) Vol. 34, Iss. 40
Closed Access | Times Cited: 110
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Binghao Zhao, Huanzhang Li, Yu Xia, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 96
Live Macrophage-Delivered Doxorubicin-Loaded Liposomes Effectively Treat Triple-Negative Breast Cancer
Lan Yang, Yongshun Zhang, Yu Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 6, pp. 9799-9809
Closed Access | Times Cited: 76
CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment
Jiachen Wen, Siyuan Wang, Rongxian Guo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114884-114884
Closed Access | Times Cited: 72
Emerging Targeted Therapies for HER2-Positive Breast Cancer
María F. Mercogliano, Sofía Bruni, Florencia Mauro, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1987-1987
Open Access | Times Cited: 72
Tumor-associated macrophages: an effective player of the tumor microenvironment
Udit Basak, Tania Sarkar, Sumon Mukherjee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 72
Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression
Ming Li, Hao Xu, Yanhua Qi, et al.
Oncogene (2022) Vol. 41, Iss. 41, pp. 4618-4632
Open Access | Times Cited: 70
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Nelson M. LaMarche, Samarth Hegde, Matthew D. Park, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 166-174
Open Access | Times Cited: 70
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 55
Extracellular Vesicles‐Derived Hybrid Nanoplatforms for Amplified CD47 Blockade‐Based Cancer Immunotherapy
Lu Tang, Yue Yin, Yuqi Cao, et al.
Advanced Materials (2023) Vol. 35, Iss. 35
Closed Access | Times Cited: 54
Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions
Peilin Lu, Dongxue Ruan, Meiqi Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting
Christina Malainou, Shifaa M Abdin, Nico Lachmann, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 19
Open Access | Times Cited: 50
Successes and challenges in clinical gene therapy
Donald B. Kohn, Yvonne Y. Chen, Melissa J. Spencer
Gene Therapy (2023) Vol. 30, Iss. 10-11, pp. 738-746
Open Access | Times Cited: 50
3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip
Wenxiu Li, Zhihang Zhou, Xiaoyu Zhou, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 18
Open Access | Times Cited: 48
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
Marco Ruella, Felix Korell, Patrizia Porazzi, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 976-995
Open Access | Times Cited: 48
A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis‐Targeting Chimeras Enhanced Immunotherapy
Yaping Wu, Xiaowei Chang, Guizhu Yang, et al.
Advanced Materials (2023) Vol. 35, Iss. 12
Open Access | Times Cited: 47
The promising role of tumor-associated macrophages in the treatment of cancer
Hongbin Wang, Xueying Wang, Xin Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101041-101041
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top